Zebinix News
Most Popular Zebinix Story
Eisai inks deal for epilepsy drug
Japan's Eisai has forged a €95 million licensing deal with Portugal's Bial to market the anti-epileptic Zebinix in Europe following an approval. Bial is hoping for a second-quarter EMEA approval Read more...
Latest Headlines
- February 19, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
